NCAM1 and neoplasm: As shown in Figure 1C and 1D, the frequencies of CD3+CD56+ NKT-like cells in tumors were significantly lower than those in non-tumor tissues (4.44%, 0.52%-18.10% vs. 7.20%, 0.23%-26.50%, P<0.01).